F-18 FDG for tamc, hawaii
Ended Purchase Order Awarded Last action
- Contract number
- W81K0221P0165
- Awardee
-
Hamamatsu / Queen's Pet Imaging Center, LLC UEI N3FULYMBHGC6
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $573,424
Award facts
- Opportunity
-
- Fluedeoxyglucose 18 Pre-Solicitation · W81K0221Q0166 · Posted Jul 1, 2021
- Contract value 39% obligated
- $1,468,184.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 621512 Diagnostic Imaging Centers
- Set-aside
- No set-aside
- Competition
- 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Honolulu, HI 96813, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$242,989 | |
| Supplemental Agreement for work within scope | -$484,946 | |
| Funding Only Action | $573,424 | |
| Exercise an Option | $0 | |
| Funding Only Action | $545,454 | |
| Supplemental Agreement for work within scope | -$174,653 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $523,960 | |
| Original award | $0 |
About this award
The Defense Health Agency awarded a firm fixed-price purchase order to Hamamatsu / Queen's Pet Imaging Center, LLC for the supply of Fluorine 18 Fluorodeoxyglucose (F-18 FDG), a positron emission tomography radiopharmaceutical, to Tripler Army Medical Center (TAMC) in Honolulu, Hawaii. The contract, valued at $1.47 million with an ultimate completion date of September 30, 2024, was awarded on October 1, 2021, following a pre-solicitation notice posted in July 2021. No set-aside designation was used in this procurement. The requirement called for a qualified vendor capable of providing F-18 FDG on an as-needed basis with rapid shipping capabilities to accommodate the radiopharmaceutical's limited shelf-life for use by TAMC's Department of Radiology.
The award was modified in FY24 to provide additional funding for continued supply of this critical medical imaging agent. Tripler Army Medical Center, as a major Department of Defense medical facility, utilizes positron emission tomography imaging for oncology, neurology, and cardiology applications in support of military beneficiary care and treatment. The Defense Health Agency's procurement of this specialized pharmaceutical demonstrates the importance of maintaining reliable supply chains for advanced diagnostic capabilities at military medical treatment facilities.
Quick answers
Who was awarded contract W81K0221P0165?
W81K0221P0165 was awarded to Hamamatsu / Queen's Pet Imaging Center, LLC by Medical Command (Department of the Army) on October 1, 2021.
How much is contract W81K0221P0165 worth?
The government has obligated $573,424 on W81K0221P0165. Its current value, with exercised options, is $1,468,185.
Which agency awarded contract W81K0221P0165?
Medical Command (Department of the Army) awarded W81K0221P0165, with funding from Defense Health Agency (Department of Defense).
Was contract W81K0221P0165 competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award